Ewa Orlewska Selected Research

Ewa Orlewska Research Topics

3	Acromegaly 01/2019 - 01/2013
2	Rheumatoid Arthritis 09/2010 - 01/2010
1	COVID-19 01/2023
1	Type 2 Diabetes Mellitus (MODY) 11/2020
1	Melanoma (Melanoma, Malignant) 08/2019
1	Chronic Disease (Chronic Diseases) 08/2016
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2015
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2014
1	Coronary Disease (Coronary Heart Disease) 01/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2008
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2008
1	Heart Diseases (Heart Disease) 01/2008
1	Chronic Hepatitis C 10/2004
1	Myocardial Infarction 01/2003
1	Acute Coronary Syndrome 01/2003
1	Fibrosis (Cirrhosis) 09/2002

3	lanreotide (Somatuline)FDA Link 01/2015 - 01/2013
2	Glutathione (Reduced Glutathione)IBA 01/2023 - 11/2020
2	TransferasesIBA 01/2023 - 11/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	isoleucylvalineIBA 01/2023
1	O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA 01/2023
1	IpilimumabIBA 08/2019
1	VemurafenibIBA 08/2019
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2019
1	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2015
1	Antirheumatic Agents (DMARD)IBA 09/2010
1	Rituximab (Mabthera)FDA Link 01/2010
1	Perindopril FDA LinkGeneric 01/2008
1	Ribavirin (Virazole)FDA LinkGeneric 10/2004
1	Interferon-alpha2bIBA 10/2004
1	peginterferon alfa-2b (Pegintron)FDA Link 10/2004
1	peginterferon alfa-2a (Pegasys)FDA Link 10/2004
1	InterferonsIBA 10/2004
1	Heparin (Liquaemin)FDA LinkGeneric 01/2003
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2003
1	Hepatitis B e AntigensIBA 09/2002
1	Biomarkers (Surrogate Marker)IBA 09/2002